Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Gamida Cell Ltd.
  6. News
  7. Analyst Reco.
    GMDA   IL0011552663

GAMIDA CELL LTD.

(GMDA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Analyst Recommendations on GAMIDA CELL LTD.
2021Needham Adjusts Price Target on Gamida Cell to $12 from $14, Keeps Buy Rating
MT
2021Oppenheimer Adjusts Gamida Cell PT to $15 From $17, Maintains Outperform Rating
MT
2021RBC Cuts Price Target on Gamida Cell to $11 From $14, Citing Setback to Omidubicel Fili..
MT
2021GAMIDA CELL : RBC Capital Adjusts Gamida Cell PT to $14 From $12, Maintains Outperform - S..
MT
2021GAMIDA CELL : Needham Adjusts Price Target on Gamida Cell to $14 From $17, Maintains Buy R..
MT
2020GAMIDA CELL : Oppenheimer Adjusts Gamida Cell PT to $17 From $20, Maintains Outperform Rat..
MT
2020GAMIDA CELL : RBC Capital Adjusts Gamida Cell's Price Target to $12 From $13, Maintains Ou..
MT
Upcoming event on GAMIDA CELL LTD.
08/10/22Interim 2022 Earnings Release (Projected)
Upcoming sector events
07/27/22VERTEX PHARMACEUTICALS INCORPORATED : Interim 2022 Earnings Release (Projected)
07/27/22GILEAD SCIENCES, INC. : Interim 2022 Earnings Release (Projected)
08/04/22REGENERON PHARMACEUTICALS, INC. : Interim 2022 Earnings Release (Projected)
08/08/22BIONTECH SE : Interim 2022 Earnings Release
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs